Ipca Laboratories Ltd Nine Monthly Results

Gross Sales

5,672.03

4,732.69

4,540.69

4,305.33

3,574.95

Excise Duty

0

0

0

0

0

Net Sales

5,672.03

4,732.69

4,540.69

4,305.33

3,574.95

Other Operating Income

0

0

0

0

0

Other Income

173.86

89.23

52.03

42.92

53.27

Total Income

5,845.89

4,821.92

4,592.72

4,348.25

3,628.22

Total Expenditure

4,711.81

3,991.08

3,463.11

2,995.09

2,842.19

PBIDT

1,134.08

830.84

1,129.61

1,353.16

786.03

Interest

108.9

27.09

4.31

7.34

12.83

PBDT

1,025.18

803.75

1,125.3

1,345.82

773.2

Depreciation

259.11

192.02

171.48

156.67

146.56

Minority Interest Before NP

0

0

0

0

0

Tax

238.36

192.46

174.95

212.92

111.87

Deferred Tax

1.41

12.53

21.06

-3.71

-5.74

Reported Profit After Tax

526.3

406.74

757.81

979.94

520.51

Minority Interest After NP

33.83

6.05

3.96

1.27

0.2

Net Profit after Minority Interest

487.76

394.8

753.85

978.67

520.31

Extra-ordinary Items

46.72

0

0

0

0

Adjusted Profit After Extra-ordinary item

441.04

394.8

753.85

978.67

520.31

EPS (Unit Curr.)

19.23

15.56

29.71

77.42

41.2

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

25.37

25.37

25.37

25.37

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.99

17.55

24.87

31.42

21.98

PBDTM(%)

18.07

16.98

24.78

31.25

21.62

PATM(%)

9.27

8.59

16.68

22.76

14.55